Furthermore, the endocannabinoid/endovanilloid system, composed of two G-protein coupled cannabinoid receptors (CB1 and CB2) and TRPV1, and their respective ligands and enzymes, is targeted in a novel therapeutic approach for T-cell acute lymphoblastic leukemia (T-ALL). This evidence concerns the gene CNR2 and acute lymphoblastic leukemia.